Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ryotaro Eda"'
Autor:
Ryotaro Eda, Shotaro Maehana, Aki Hirabayashi, Masaki Nakamura, Takashi Furukawa, Shinsuke Ikeda, Kouji Sakai, Fumiaki Kojima, Kazunari Sei, Masato Suzuki, Hidero Kitasato
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss , Pp 180-182 (2021)
Objectives: The Klebsiella pneumoniae carbapenemase (blaKPC) gene is one of the most widespread carbapenemase genes in the world. However, there are few reports on KPC-producing bacteria in Japan. The aim of this study was therefore to investigate KP
Externí odkaz:
https://doaj.org/article/090c4f68405740b78f1739ab9cf3e3bf
Autor:
Masaki Nakamura, Hayato Kawada, Hiroki Uchida, Yusuke Takagi, Shuichi Obata, Ryotaro Eda, Hideaki Hanaki, Hidero Kitasato
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245732 (2021)
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. Due to an increase in its administration for combating MRSA infections, DAP non-susceptible (DAP-NS) MRSA
Externí odkaz:
https://doaj.org/article/be8105dffef947239623c247b50db437
Autor:
Makoto Kubo, Ryotaro Eda, Shotaro Maehana, Hiroshi Fuketa, Norihiro Shinkai, Naohisa Kawamura, Hidero Kitasato, Hideaki Hanaki
Publikováno v:
Journal of Water & Health; Mar2024, Vol. 22 Issue 3, p601-611, 11p
Autor:
Lokadi Pierre Luhata, Yoshiko Iizuka, Ryotaro Eda, Hiroshi Uchida, Chick, Christian Nanga, Makoto Kubo, Toyonobu Usuki
Publikováno v:
Chemistry Letters; Feb2024, Vol. 53 Issue 2, p1-4, 4p
Autor:
Ryotaro Eda, Hisakazu Yano, Ryuichi Nakano, Yoko Takayama, Shotaro Maehana, Hidero Kitasato, Masaki Nakamura
Publikováno v:
Journal of Infection and Chemotherapy. 26:667-671
Background The increasing number of carbapenemase-producing Enterobacteriaceae (CPE) has become a global problem. Most carbapenemases detected in Japan are imipenemase, which is an imipenem-degrading enzyme with low ability; thus, CPE could have been
Autor:
Hidero Kitasato, Tatsuhiko Wada, Yuzuru Adachi, Satowa Suzuki, Makoto Kuroda, Masashi Takaso, Mari Matsui, Shin Nihonyanagi, Hideaki Hanaki, Tsuyoshi Sekizuka, Ryotaro Eda, Yoko Takayama, Hidehito Matsui
Publikováno v:
Infection and Drug Resistance. 13:561-566
Purpose New Delhi metallo-β-lactamase 5 (NDM-5) shows stronger resistance to carbapenems and broad-spectrum cephalosporins than NDM-1 because NDM-5 differs from NDM-1 by two amino acid substitutions. In this study, our aim was to characterize a NDM-
Autor:
Kazunari Sei, Takashi Furukawa, Masaki Nakamura, Ryotaro Eda, Shotaro Maehana, Fumiaki Kojima, Masato Suzuki, Hidero Kitasato, Shinsuke Ikeda, Aki Hirabayashi, Kouji Sakai
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss, Pp 180-182 (2021)
Objectives The Klebsiella pneumoniae carbapenemase (blaKPC) gene is one of the most widespread carbapenemase genes in the world. However, there are few reports on KPC-producing bacteria in Japan. The aim of this study was therefore to investigate KPC
Emergence of a novel mobile RND-type efflux pump gene cluster,tmexC3D2-toprJ1b, inPseudomonasspecies
Autor:
Aki Hirabayashi, Kazunari Sei, Masato Suzuki, Kouji Sakai, Takashi Furukawa, Nagi Niida, Shotaro Maehana, Ryotaro Eda, Hidero Kitasato
Tigecycline exhibits promising activity against multidrug-resistant Gram-negative bacteria (MDR-GNB), whose infections are difficult to treat with antimicrobials. However, mobile tigecycline resistance genes, such astmexCD-toprJ, have emerged in Ente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92e923db8686f31111637607c7f27292
https://doi.org/10.1101/2021.07.26.453812
https://doi.org/10.1101/2021.07.26.453812
Autor:
Hiroki Uchida, Shuichi Obata, Ryotaro Eda, Masaki Nakamura, Yusuke Takagi, Hidero Kitasato, Hideaki Hanaki, Hayato Kawada
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245732 (2021)
PLoS ONE
PLoS ONE
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. Due to an increase in its administration for combating MRSA infections, DAP non-susceptible (DAP-NS) MRSA
Autor:
Shotaro, Maehana, Ryotaro, Eda, Aki, Hirabayashi, Nagi, Niida, Masaki, Nakamura, Takashi, Furukawa, Shinsuke, Ikeda, Fumiaki, Kojima, Kouji, Sakai, Kazunari, Sei, Hidero, Kitasato, Masato, Suzuki
Publikováno v:
International journal of antimicrobial agents. 57(5)